← back to search

Çharles N. Bernstein

University of Manitoba · CA
Area of research
Genetics · Epidemiology
Research interest
Dr. Bernstein's contributions to the field have been recognized with numerous awards and honors, including being elected to the Canadian Academy of Health Sciences in 2008, being named the inaugural Bingham Chair in Gastroenterology at the University of Manitoba in 2009, receiving the Canadian Association of Gastroenterology Research Excellence Award in 2012, being elected into the Royal Society of Canada-Life Sciences Division of the Academy of Science in 2012, being appointed as a Distinguished Professor of Medicine at University of Manitoba in 2014, and receiving the Dr. John M. Bowman Memorial Winnipeg Rh Institute Foundation Award in 2016, recognizing outstanding research accomplishments by a senior University of Manitoba faculty.
h-index
121
citations
67,907
works
1,359
NIH funding
primary concept
Medicine
email

Recent publications

Global evolution of inflammatory bowel disease across epidemiologic stages
Nature 2025cited by 259position: middledoi
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response
Nature Reviews Gastroenterology & Hepatology 2025cited by 46position: middledoi
Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database
Nature Communications 2025cited by 10position: middledoi
Metabolomics reveal distinct molecular pathways associated with future risk of Crohn’s Disease
Gut Microbes 2025cited by 3position: middledoi
Noninvasive, microbiome-based diagnosis of inflammatory bowel disease
Nature Medicine 2024cited by 108position: middledoi
Environmental Factors Associated With Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project
Clinical Gastroenterology and Hepatology 2024cited by 28position: middledoi
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn’s Disease
Gastroenterology 2024cited by 20position: middledoi
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease
Clinical Gastroenterology and Hepatology 2024cited by 16position: middledoi
Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis
Communications Medicine 2024cited by 15position: middledoi
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries
Nature Genetics 2023cited by 205position: middledoi
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
˜The œLancet. Gastroenterology & hepatology 2023cited by 187position: middledoi
Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives
Gastroenterology 2023cited by 186position: middledoi
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis
Gastroenterology 2023cited by 86position: middledoi
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis
Gut 2023cited by 71position: middledoi
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
˜The œLancet. Gastroenterology & hepatology 2023cited by 68position: middledoi
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)
BMC Medical Research Methodology 2023cited by 38position: middledoi
Exploring the Impact of Covid-19-Related Perceptions on Psychological Distress and Quality of Life in an International Gastrointestinal Cohort Over Time Guided by the Common Sense Model
Journal of Clinical Psychology in Medical Settings 2023cited by 5position: middledoi
Proportionality-based association metrics in count compositional data
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 0position: middledoi
Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
Clinical Gastroenterology and Hepatology 2022cited by 267position: middledoi
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease
Gastroenterology 2022cited by 188position: middledoi
Unfermented β-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients
Gastroenterology 2022cited by 175position: middledoi
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
˜The œLancet. Gastroenterology & hepatology 2022cited by 144position: middledoi
Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation
Gastroenterology 2022cited by 110position: middledoi
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease
Gastroenterology 2022cited by 79position: middledoi
Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium
˜The œLancet. Gastroenterology & hepatology 2022cited by 31position: middledoi
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium
˜The œLancet. Gastroenterology & hepatology 2021cited by 153position: middledoi
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium
˜The œLancet. Gastroenterology & hepatology 2021cited by 113position: middledoi
The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
Annals of Clinical and Translational Neurology 2021cited by 67position: middledoi
Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group
˜The œLancet. Gastroenterology & hepatology 2021cited by 66position: lastdoi
Awarded by Med II class (Class of 2021) for teaching awards in the following categories:
2021cited by 0position: selected

Grants

No grants ingested yet.

Frequent collaborators

Alain Bitton · McGill University Health Centre10 papers (2012–2025)Gilaad G. Kaplan · Mount Sinai Hospital7 papers (2017–2025)Harminder Singh · Cardiff University7 papers (2015–2019)Remo Panaccione · Nutrition-Génétique et Exposition aux Risques Environnementaux7 papers (2012–2025)Jitender Sareen · Dalhousie University6 papers (2015–2018)John D. Fisk · Dalhousie University6 papers (2015–2018)Eric I. Benchimol · University of Toronto6 papers (2012–2019)James M. Bolton · The University of Texas Southwestern Medical Center6 papers (2015–2018)John R. Walker · Impact6 papers (2015–2018)Geoffrey C. Nguyen · Monash Health6 papers (2014–2019)Carol Hitchon · Research Manitoba5 papers (2017–2018)Renée El‐Gabalawy · University of Calgary5 papers (2017–2018)Siew C. Ng · United Christian Hospital5 papers (2013–2025)David T. Rubin · University of California System5 papers (2020–2025)Laura E. Targownik · Sinai Health System5 papers (2015–2019)Sanjay K. Murthy · Ottawa Hospital5 papers (2017–2019)Alexander Singer · Dalhousie University5 papers (2015–2018)Lisa M. Lix · College of Community and Global Health5 papers (2017–2018)Ali Mirza · University of Michigan–Ann Arbor4 papers (2019–2024)Helen Tremlett · University of British Columbia Hospital4 papers (2019–2024)